Mj Lab Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 07-07-2024
- Paid Up Capital ₹ 1.50 M
as on 07-07-2024
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.20 M
as on 07-07-2024
- Revenue 26.08%
(FY 2020)
- Profit 104.89%
(FY 2020)
- Ebitda 138.60%
(FY 2020)
- Net Worth 5.12%
(FY 2020)
- Total Assets -5.94%
(FY 2020)
About Mj Lab
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹8.20 M.
Dileepan Poongothai, Pradeep Pillai, Jagadeeswaran Pillai, and One other member serve as directors at the Company.
- CIN/LLPIN
U24200MH1996PTC097388
- Company No.
097388
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Feb 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Mj Lab Private Limited offer?
Mj Lab Private Limited offers a wide range of products and services, including Pharmaceutical Services, Pharmaceutical Testing Services, Actuarial & Risk Management, Risk Management Services.
Who are the key members and board of directors at Mj Lab?
Board Members(4)
Financial Performance and Corporate Structure Insights of Mj Lab.
Mj Lab Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 26.08% increase. The company also saw a substantial improvement in profitability, with a 104.89% increase in profit. The company's net worth moved up by a moderate rise of 5.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mj Lab?
In 2020, Mj Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mj Research And Development Services Private Limited
Active
4 years 10 months Jagadeeswaran Pillai is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Creation Date: 14 Dec 2012 | ₹5.20 M | Open |
State Bank Of India Creation Date: 23 Oct 1997 | ₹3.00 M | Open |
How Many Employees Work at Mj Lab?
Mj Lab has a workforce of 33 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mj Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mj Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
